These data all together suggest that Treg cell stability and their responsiveness to the IL-2 can be controlled by different miRNA therefore opening new avenues for potential therapeutic targets for the prevention and treatment of autoimmune disorders. The gene discussed is IL2; the disease is autoimmune disease.